Critical Care

official impact factor 4.60

Open Access Highly Access

Antithrombin supplementation for anticoagulation during continuous hemofiltration in critically ill patients with septic shock: a case-control study

Damien du Cheyron*, Bruno Bouchet, Cédric Bruel, Cédric Daubin, Michel Ramakers and Pierre Charbonneau

Critical Care 2006, 10:R45 doi:10.1186/cc4853

Accesses  

  • Last 30 days: 38 accesses
  • Last year: 470 accesses
  • All time: 5505 accesses

Cited by

BioMed Central: 4 citations

Research   Open Access Highly Accessed

Hemostasis during low molecular weight heparin anticoagulation for continuous venovenous hemofiltration: a randomized cross-over trial comparing two hemofiltration rates

Heleen M Oudemans-van Straaten, Muriel van Schilfgaarde, Pascal J Molenaar, Jos PJ Wester, Anja Leyte Critical Care 2009, 13:R193 (3 December 2009)

Review   Free Highly Accessed

Clinical review: Patency of the circuit in continuous renal replacement therapy

Michael Joannidis, Heleen M Oudemans-van Straaten Critical Care 2007, 11:218 (12 July 2007)

This article is part of a collection on Renal replacement therapy

Research   Open Access

Four-day antithrombin therapy does not seem to attenuate hypercoagulability in patients suffering from sepsis

Christopher Gonano, Christian Sitzwohl, Eva Meitner, Christian Weinstabl, Stephan C Kettner Critical Care 2006, 10:R160 (15 November 2006)

Research   Open Access Highly Accessed

The effects of continuous venovenous hemofiltration on coagulation activation

Catherine SC Bouman, Anne-Cornélie JM de Pont, Joost CM Meijers, Kamran Bakhtiari, Dorina Roem, Sacha Zeerleder, Gertjan Wolbink, Johanna C Korevaar, Marcel Levi, Evert de Jonge Critical Care 2006, 10:R150 (27 October 2006)